Suppr超能文献

去氧肾上腺素对葡萄膜炎患者眼部疼痛和炎症强度的影响。

The effect of phenylephrine on pain and flare intensity in eyes with uveitis.

作者信息

Zaczek A, Zetterström C

机构信息

St. Erik's Eye Hospital, Karolinska Institute, Stockholm, Sweden.

出版信息

Acta Ophthalmol Scand. 2000 Oct;78(5):516-8. doi: 10.1034/j.1600-0420.2000.078005516.x.

Abstract

PURPOSE

To investigate the influence of protein concentration in the anterior chamber, measured by laser flare meter, on pain sensation after phenylephrine instillation in patients with iridocyclitis.

METHODS

Twenty-five consecutive patients with iridocyclitis were included. Patients with cataract, exfoliation syndrome, diabetes mellitus, glaucoma or any other previous ocular diseases or ocular surgery were excluded. Patients were divided into two groups: Group 1--without fibrinoid reaction (FR) in the anterior chamber (18 patients), and Group 2--with FR (7 patients). Protein concentration in the anterior chamber was measured with laser flare meter (FC 500, Kowa Co., Japan). Pupil size was measured by Alcon Tilo Scale, and pain sensation was estimated by Visual Analogue Scale (VAS, Kabi Pharmacia). All measurements were done before and 1 hour after topical instillation of 10% phenylephrine hydrochloride into the subconjunctival sac of the inflamed eyes.

RESULTS

Eyes with iridocyclitis and fibrinoid reaction (FR) have a higher flare intensity compared to those without FR (p<0.05). Pupil size was significantly increased after phenylephrine instillation in both study groups (Wilcoxon test, p<0.05). The VAS pain and flare intensity were significantly decreased in group without FR after phenylephrine instillation (Group 1) compared to values before treatment (Wilcoxon test, p<0.05). In eyes with FR (Group 2), no significant influence of phenylephrine instillation was found on VAS pain and flare intensity.

CONCLUSIONS

After phenylephrine instillation, flare intensity and pain were significantly decreased only in eyes with iridocyclitis and without FR. The decreasing level of flare intensity, and paralysis of the pupil after phenylephrine instillation seem to alleviate pain in those eyes.

摘要

目的

通过激光 flare 仪测量前房内蛋白质浓度,探讨其对虹膜炎患者滴用去氧肾上腺素后疼痛感觉的影响。

方法

纳入 25 例连续的虹膜炎患者。排除患有白内障、剥脱综合征、糖尿病、青光眼或任何其他既往眼部疾病或眼部手术史的患者。患者分为两组:第 1 组——前房无纤维蛋白样反应(FR)(18 例患者),第 2 组——有 FR(7 例患者)。使用激光 flare 仪(FC 500,日本兴和株式会社)测量前房内蛋白质浓度。通过爱尔康 Tilo 量表测量瞳孔大小,通过视觉模拟量表(VAS,瑞典法玛西亚公司)评估疼痛感觉。所有测量均在向患眼结膜下囊内局部滴用 10%盐酸去氧肾上腺素之前和之后 1 小时进行。

结果

与无 FR 的眼睛相比,患有虹膜炎且有纤维蛋白样反应(FR)的眼睛 flare 强度更高(p<0.05)。在两个研究组中,滴用去氧肾上腺素后瞳孔大小均显著增加(Wilcoxon 检验,p<0.05)。与治疗前的值相比,滴用去氧肾上腺素后第 1 组(无 FR 的组)的 VAS 疼痛和 flare 强度显著降低(Wilcoxon 检验,p<0.05)。在有 FR 的眼睛(第 2 组)中,未发现滴用去氧肾上腺素对 VAS 疼痛和 flare 强度有显著影响。

结论

滴用去氧肾上腺素后,仅在患有虹膜炎且无 FR 的眼睛中,flare 强度和疼痛显著降低。滴用去氧肾上腺素后 flare 强度的降低水平以及瞳孔麻痹似乎减轻了这些眼睛的疼痛。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验